Literature DB >> 26651430

Improved Survival in Down Syndrome over the Last 60 Years and the Impact of Perinatal Factors in Recent Decades.

Emma J Glasson1, Angela Jacques2, Kingsley Wong2, Jenny Bourke2, Helen Leonard2.   

Abstract

OBJECTIVE: To calculate the survival of people with Down syndrome over the past 60 years and the influence of major perinatal factors by using linked population-based data. STUDY
DESIGN: A data linkage between 2 Western Australian (WA) data sets (the Register for Developmental Anomalies and the Intellectual Disability Exploring Answers database) was used to identify 772 children born with Down syndrome in WA from 1980-2010. Perinatal and mortality data were extracted from the WA Midwives Information System and WA death registrations and compared with the remaining WA population born during that same era. An additional 606 children with Down syndrome living in WA prior to 1980 were available from a disability services database and were used for predicting survival into adulthood.
RESULTS: Overall, for cases born 1953-2010, 88% (95% CI 86%, 90%) survived to 5 years of age, 87% (95% CI 85%, 89%) to 10 years, and 83% (95% CI 80%, 85%) to 30 years. Children live-born with Down syndrome were significantly more likely (all P > .001) to have mothers older than 35 years (32.7% vs 13.4%), a gestational age less than 37 weeks (23.8% vs 7.9%), a cesarean delivery (28.9% vs 23.0%), and a birth weight less than 2500 g (20.4% vs 6.1%). Down syndrome survival was reduced in the presence of a cardiovascular defect, younger gestational age, low birth weight, or earlier birth years.
CONCLUSIONS: Improved survival for children born with Down syndrome over the last 60 years has occurred incrementally, but disparities still exist for children who are preterm or have low birth weight. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26651430     DOI: 10.1016/j.jpeds.2015.10.083

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Caregiver-Reported Quality of Life in Youth with Down Syndrome.

Authors:  Melissa S Xanthopoulos; Rachel Walega; Rui Xiao; Divya Prasad; Mary M Pipan; Babette S Zemel; Robert I Berkowitz; Sheela N Magge; Andrea Kelly
Journal:  J Pediatr       Date:  2017-07-24       Impact factor: 4.406

2.  A systematic review of the biological, social, and environmental determinants of intellectual disability in children and adolescents.

Authors:  Helen Leonard; Alicia Montgomery; Brittany Wolff; Elissa Strumpher; Anne Masi; Susan Woolfenden; Katrina Williams; Valsamma Eapen; Amy Finlay-Jones; Andrew Whitehouse; Martyn Symons; Melissa Licari; Kandice Varcin; Gail Alvares; Kiah Evans; Jenny Downs; Emma Glasson
Journal:  Front Psychiatry       Date:  2022-08-25       Impact factor: 5.435

Review 3.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

4.  Is preparation a good reason for prenatal genetic testing? Ethical and critical questions.

Authors:  Marsha Michie
Journal:  Birth Defects Res       Date:  2020-03-01       Impact factor: 2.344

5.  Feasibility of Assessing Diet with a Mobile Food  Record for Adolescents and Young Adults with  Down Syndrome.

Authors:  Katherine E Bathgate; Jill L Sherriff; Helen Leonard; Satvinder S Dhaliwal; Edward J Delp; Carol J Boushey; Deborah A Kerr
Journal:  Nutrients       Date:  2017-03-13       Impact factor: 5.717

6.  Chromosomal disorders: estimating baseline birth prevalence and pregnancy outcomes worldwide.

Authors:  Sowmiya Moorthie; Hannah Blencowe; Matthew W Darlison; Stephen Gibbons; Joy E Lawn; Pierpaolo Mastroiacovo; Joan K Morris; Bernadette Modell
Journal:  J Community Genet       Date:  2017-09-26

7.  Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.

Authors:  Frances K Wiseman; Laura J Pulford; Chris Barkus; Fan Liao; Erik Portelius; Robin Webb; Lucia Chávez-Gutiérrez; Karen Cleverley; Sue Noy; Olivia Sheppard; Toby Collins; Caroline Powell; Claire J Sarell; Matthew Rickman; Xun Choong; Justin L Tosh; Carlos Siganporia; Heather T Whittaker; Floy Stewart; Maria Szaruga; Michael P Murphy; Kaj Blennow; Bart de Strooper; Henrik Zetterberg; David Bannerman; David M Holtzman; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

Review 8.  Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein.

Authors:  Wileidy Gomez; Rodrigo Morales; Vinicius Maracaja-Coutinho; Valentina Parra; Melissa Nassif
Journal:  Aging (Albany NY)       Date:  2020-01-09       Impact factor: 5.682

Review 9.  Down syndrome, accelerated aging and immunosenescence.

Authors:  Noémie Gensous; Maria Giulia Bacalini; Claudio Franceschi; Paolo Garagnani
Journal:  Semin Immunopathol       Date:  2020-07-23       Impact factor: 9.623

10.  Trisomy of Human Chromosome 21 Orthologs Mapping to Mouse Chromosome 10 Cause Age and Sex-Specific Learning Differences: Relevance to Down Syndrome.

Authors:  Ross Minter; Katheleen J Gardiner
Journal:  Genes (Basel)       Date:  2021-10-26       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.